Will 2024 be the Year We Address the Real Roots of the Opioid Crisis?
Will 2024 bring any change, or will we witness yet another record- and heart-breaking year of preventable deaths?
Telehealth Advocates: HHS Has Done Its Bit on Expanding OUD Treatment; DEA Needs to Step Up
HHS recently released a final rule that allows practitioners in Opioid Treatment Programs to start patients on methadone or buprenorphine via telehealth. However, the final rule does not apply to the broader range of providers, leading telehealth advocates to call for additional changes from the DEA.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Increasing the Impact of Opioid Settlement Funds by Investing in Health IT Infrastructure
Strengthening health IT infrastructure is a critical and necessary step toward abating the opioid crisis and evaluating the impact of how opioid settlement dollars are allocated across communities.
Talkspace, Bicycle Health Partner To Support Patients with Opioid Use Disorder
Through a new partnership, Talkspace clinicians can refer patients with opioid use disorder to Bicycle Health for its addiction services, while Bicycle Health can refer its patients to Talkspace to treat co-occurring mental health conditions.
Breaking the Cycle: Telehealth Treatment for People in Custody is Key to Recidivism Disruption
Expanding access to telehealth-based treatment programs that include medications for OUD, like buprenorphine or Sublocade, to patients as they leave custody can upend this cycle of incarceration through seamlessly following patients wherever they go next. The TREATS Act creates a legal pathway for this care to continue.
Boulder Care Extends Virtual Substance Use Disorder Treatment to Adolescents
As the opioid crisis grows for teens, Boulder Care has expanded its substance use disorder treatment to support adolescents. The company is starting its adolescent services in Washington with UnitedHealthcare Community Plan.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Ophelia, Vori Health Team Up To Support Patients with Opioid Addiction, MSK Pain
Through a new partnership, Vori Health will be able to refer its patients who report having an opioid addiction to Ophelia. On the flip side, Ophelia can refer its patients who report having MSK pain to Vori Health for non-opioid treatment.
Bicycle Health, Albertsons Form Partnership To Expand Access to OUD Treatment
Through a new partnership, Bicycle Health providers can prescribe patients buprenorphine extended release injections (otherwise known as Sublocade), which can be administered by a pharmacist at an Albertsons pharmacy.
Reading Between the Lines of the DEA’s Proposed Rules on Telemedicine
In some ways, the Drug Enforcement Agency’s (DEA) proposed rules for prescribing controlled substances via telemedicine are a sign of progress. Behavioral health could be getting some much-needed clarity, but at what cost?
Relying on Primary Care Physicians to Treat Opioid Use Disorder Fails Both Patients and Providers
The new DEA ruling is doing a disservice not only to people with OUD, but to the entire medical care system—exacerbating a condition that will most likely lead to death.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Study: More OUD Patients Stay in Treatment When Offered Buprenorphine via Telemedicine
Patients with opioid use disorder are more likely to stick with their treatment plan when offered buprenorphine via telemedicine, according to a new study. The study involved 1,378 patients, and their 180-day treatment retention rate was 56.4%.
New Collaboration Brings Opioid Use Disorder Treatment to Formerly Incarcerated Patients
The collaboration, which was announced last week, is between Bicycle Health, Wellpath and the Federal Bureau of Prisons. It will provide virtual opioid use disorder services to those living in the Bureau's residential reentry centers in 42 states.
Virtual Substance Use Disorder Companies Sound Alarm Over PHE Ending
The Covid-19 public health emergency waived a rule that required a practitioner to conduct an in-person medical exam before prescribing controlled substances via telemedicine. Once the public health emergency ends on May 11, those with substance use disorder could be greatly affected, experts are warning.
Expanding Telehealth Access Not Reducing it Will Continue Saving Lives, Mitigating Costs of the Opioid Crisis
Protectionism against (and fear of) telehealth on display from companies like Walmart and states like Alabama threaten the only effective and scalable solution to America’s opioid epidemic.
How EmpiRx Health’s value-based model led to less drug spending on mental health, decreased opioid use
EmpiRx found in its data that pharmacy claims for behavioral health treatments increased 9.4% from 2020 to 2021. For antidepressants, utilization increased 12% during this time period, but per claim spend fell 1.8%. ADHD medications saw a 20.2% increase in utilization and a 9.1% decrease in per claim spend.